Clinical Trial Update: Hemodynamic Instability Prevented With Polaramine® Infusion Before Extracorporeal Circulation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Polaramine infusion to prevent hemodynamic instability during extracorporeal circulation showed results summarized in the upda…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemodynamic Instability
• Vasoplegic Syndrome

Drugs mentioned

• Polaramine (dexchlorpheniramine)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Hemodynamic Instability, Vasoplegic Syndrome | Phase 3 | Status: COMPLETED